Pharmaceutical Sciences

morsy
  • Graduate Student / Research Assistant
Lab Phone: 806-414-9368/9251
E-Mail: ahmed.morsy@ttuhsc.edu
Mail Address: 1300 S Coulter
Amarillo, TX 79106-1786

Biography

Ahmed Morsy completed his Bachelor of Science degree in Pharmacy and Biotechnology from the German University, Cairo, Egypt in 2012. He then obtained his Master degree in Pharmaceutical Science from the University of Florida in 2016. He joined the Graduate Program in Pharmaceutical Sciences as a PhD student in the fall of 2016, and is presently working in the laboratory of Dr. Paul Trippier with the Department of Pharmaceutical Sciences.

Education:

  • MS: Pharmaceutical Science, University of Florida, Gainesville, Florida, USA, 2016
  • BS: Pharmacy and Biotechnology, German University, Cairo, Egypt, 2012

Research Interests:

Identifying and optimizing neuroprotective compounds for the treatment of Alzheimer’s disease.

Presentations:

  • Ahmed Morsy, Paul C. Trippier. "Small-Molecule Inhibitors of the Ab-ABAD Interaction as a Therapeutic Target in Alzheimer's Disease". Seventeenth Annual Research Days, TTUHSC School of Pharmacy, Amarillo, TX; June 2018.
  • Ahmed Morsy, Nihar Kinarivala, Hezhen Wang, Paul C. Trippier. "Small molecule ABAD inhibitors as a therapeutic strategy in Alzheimer’s Disease". Alzheimer's Drug Discovery Foundation, 12th Annual Drug Discovery for Neurodegeneration Conference, Arlington, VA; February 2018.
  • Ahmed Morsy, Nihar Kinarivala, Hezhen Wang, Paul C. Trippier. "Small molecule ABAD inhibitors as a therapeutic strategy in Alzheimer’s Disease". American Chemical Society, Southwest Regional Meeting, Lubbock; Oct-Nov 2017.
  • Ahmed Morsy, Nihar Kinarivala, Hezhen Wang, Paul C. Trippier. “Small molecule ABAD inhibitors as a therapeutic strategy in Alzheimer’s Disease”. Sixteenth Annual Research Days, TTUHSC School of Pharmacy, Amarillo, TX; June 2017.
  • Ahmed Morsy, Nihar Kinarivala, Hezhen Wang, Paul C. Trippier. “Small molecule ABAD inhibitors as a therapeutic strategy in Alzheimer’s Disease”. Center of Excellence for Translational Neuroscience and Therapeutics (CTNT), TTUHSC, Lubbock, TX; April 2017.

Seminars:

  • 03/28/2018 "Small-Molecule inhibitors of ABAD, a novel target to develop treatment for Alzheimer's disease"

Awards/Scholarships:

  • Young Investigator Scholarship, Alzheimer's Drug Discovery Foundation [ADDF], 12th Annual Drug Discovery for Neurodegeneration Conference [DDNC]: An Educational Course on Translating Research into Drugs, Washington, DC; February 2018.

Memberships:

  • Graduate Student Association at Amarillo, 2016-present.
  • American Association of Pharmaceutical Scientists, 2016-present.
Placeholder image

Give

Optional subheading text

View more
Placeholder image

Give

Optional subheading text

View more

Got Questions?

We're hear to help. Contact us if you have questions.

John Doe

(555) 555 - 5555

john.doe@email.edu

example image

Spotlight Example Header

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.